300077.SZ
300077.SZ
CNE100000NT8
NSING
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 37/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.36x
Defensive
Volatility (5Y p.a.)
59.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-79.6%
5-Year Horizon
Sharpe Ratio
-0.17
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -24.5%
3 Years 68.2% -60.3% 0.19 +15.6%
5 Years 59.8% -79.6% -0.17 -7.4%
10 Years 58.4% -84.5% -0.03 +0.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 High valuation risk: Avg P/E of 70.3 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (68.2%) is noticeably higher than the 5Y average (59.8%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (59.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.5% in the extended horizon.
ende